- CEO
- Byeong-Wuk Lee
- Full Time Employees
- 23
- Sector
- Retail trade
- Industry
- Drugstore chains
- Address
- Seoul South Korea
- IPO Date
- Oct 22, 2019
- Business
- Pharmsville Co., Ltd. is a South Korea-based healthcare and biotechnology company primarily engaged in the research, development, manufacturing, and distribution of health functional foods, dietary supplements, inner beauty products, and functional cosmetics. Founded in 2000 and headquartered in Seoul, South Korea, the company operates across the nutraceutical, preventive healthcare, and cosmeceutical sectors, serving domestic and international consumer markets. Pharmsville commercializes proprietary formulations through a diverse brand portfolio that includes Applephenon, Devil's Diet, Vitamin Village, and Lavieng. The company's core product and service offerings comprise weight management and metabolic health solutions, including apple polyphenol extracts, Garcinia cambogia formulas, and dietary fiber supplements; cognitive and neurological health formulations, featuring phosphatidylserine brain health and memory support complexes; ocular wellness products, consisting of lutein, zeaxanthin, and astaxanthin eye health formulas; inner beauty and anti-aging treatments, including low-molecular fish collagen peptides, oral hyaluronic acid, and glutathione supplements; gastrointestinal and immune health solutions, encompassing multi-strain probiotics, prebiotics, and zinc formulations; joint and bone health products, featuring methylsulfonylmethane, calcium, and vitamin D complexes; general wellness and vitality products, including multivitamin complexes, milk thistle liver support formulas, and fermented red ginseng extracts; functional skincare and cosmeceutical lines; and algorithm-driven personalized dietary supplement consultation and subscription services. The company distributes its products through omnichannel networks, including television home shopping broadcasts, direct-to-consumer online shopping malls, duty-free retailers, pharmacies, and major offline retail chains, with expanding export footprints across Greater China, Southeast Asia, North America, and Europe. In recent operational and strategic developments, Pharmsville has diversified its business model by expanding its algorithm-powered personalized functional food service, providing individualized nutritional diagnostic assessments and custom-portioned packaging. The company has also expanded its research infrastructure through its Magok R&D Center in Seoul, advancing clinical validation for novel proprietary bio-ingredients and functional food raw materials. In addition, Pharmsville has accelerated international expansion via direct cross-border e-commerce storefronts on major Asian digital commerce platforms and broadened its commercial scope into the pet healthcare segment with the launch of specialized functional supplements for companion animals.